Mast cells produce novel shorter forms of perlecan that contain functional endorepellin a role in angiogenesis and wound healing

Journal of Biological Chemistry

Volumn 288, Issue 5, 2013, Pages 3289-3304

  Jung, Moonsun ^a   Lord, Megan S ^a   Cheng, Bill ^a   Lyons, J Guy ^b   Alkhouri, Hatem ^b   Hughes, J Margaret ^b   McCarthy, Simon J ^c   Iozzo, Renato V ^d   Whitelock, John M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c HemCon Medical Technologies Inc   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; C-TERMINAL REGIONS; DOMAIN SPECIFIC; ENDOREPELLIN; EXTRACELLULAR; GROWTH FACTOR; HEPARAN SULFATES; HUMAN MAST CELLS; INTEGRINS; MAST CELLS; MUCOSAL TISSUES; N-TERMINAL SEQUENCING; PERLECAN; PROTEIN CORE; PROTEOGLYCANS; WOUND HEALING;

ANTIBODIES; CELL CULTURE; ENDOTHELIAL CELLS; MOLECULAR MASS; TISSUE;

ENZYME ACTIVITY;

ENDOREPELLIN; MEMBRANE PROTEIN; MESSENGER RNA; MONOCLONAL ANTIBODY; PERLECAN; PROTEINASE; PROTEOHEPARAN SULFATE; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 2;

AMINO TERMINAL SEQUENCE; ANGIOGENESIS; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL ASSAY; CELL CULTURE; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MAST CELL; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROCESSING; PROTEIN SYNTHESIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WOUND HEALING;

AMINO ACID SEQUENCE; ANIMALS; CELL ADHESION; CELL LINE; CELL MOVEMENT; CORONARY VESSELS; ENDOTHELIAL CELLS; GLYCOSAMINOGLYCANS; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; INTEGRIN ALPHA2BETA1; LUNG; MAST CELLS; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDE FRAGMENTS; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; PROTEOGLYCANS; RATS; RNA, MESSENGER; VESICULAR TRANSPORT PROTEINS; WOUND HEALING;

EID: 84873289627     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.387811     Document Type: Article

References (59)

1. Whitelock, J. M., and Iozzo, R. V. (2005) Heparan sulfate. A complex polymer charged with biological activity. Chem. Rev. 105, 2745-2764
2. Knox, S., Melrose, J., and Whitelock, J. (2001) Electrophoretic, biosensor, and bioactivity analyses of perlecans of different cellular origins. Proteomics 1, 1534-1541
3. Patel, V. N., Knox, S. M., Likar, K. M., Lathrop, C. A., Hossain, R., Eftekhari, S., Whitelock, J. M., Elkin, M., Vlodavsky, I., and Hoffman, M. P. (2007) Heparanase cleavage of perlecan heparan sulfate modulates FGF10 activity during ex vivo submandibular gland branching morphogenesis. Development 134, 4177-4186
4. Chuang, C. Y., Lord, M. S., Melrose, J., Rees, M. D., Knox, S. M., Freeman, C., Iozzo, R. V., and Whitelock, J. M. (2010) Heparan sulfate-dependent signaling of fibroblast growth factor 18 by chondrocyte-derived perlecan. Biochemistry 49, 5524-5532
5. Mongiat, M., Taylor, K., Otto, J., Aho, S., Uitto, J., Whitelock, J. M., and Iozzo, R. V. (2000) The protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7. J. Biol. Chem. 275, 7095-7100
6. Smith, S. M., West, L. A., and Hassell, J. R. (2007) The core protein of growth plate perlecan binds FGF-18 and alters its mitogenic effect on chondrocytes. Arch. Biochem. Biophys. 468, 244-251
7. Woodall, B. P., Nystrom, A., Iozzo, R. A., Eble, J. A., Niland, S., Krieg, T., Eckes, B., Pozzi, A., and Iozzo, R. V. (2008) Integrin α2β1 is the required receptor for endorepellin angiostatic activity. J. Biol. Chem. 283, 2335-2343
8. Goyal, A., Pal, N., Concannon, M., Paul, M., Doran, M., Poluzzi, C, Sekiguchi, K., Whitelock, J. M., Neill, T., and Iozzo, R. V. (2011) Endorepellin, the angiostatic module of perlecan, interacts with both the α2β1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2). A dual receptor antagonism. J. Biol. Chem. 286, 25947-25962
9. Diegelmann, R. F., and Evans, M. C. (2004) Wound healing. An overview of acute, fibrotic and delayed healing. Front. Biosci. 9, 283-289
10. Hawkins, R. A., Claman, H. N., Clark, R. A., and Steigerwald, J. C. (1985) Increased dermal mast cell populations in progressive systemic sclerosis. A link in chronic fibrosis? Ann. Intern. Med. 102, 182-186
11. Samoszuk, M., Kanakubo, E., and Chan, J. K. (2005) Degranulating mast cells in fibrotic regions of human tumors and evidence that mast cell heparin interferes with the growth of tumor cells through a mechanism involving fibroblasts. BMC Cancer 5, 121
12. Goto, T., Befus, D., Low, R., and Bienenstock, J. (1984) Mast cell heterogeneity and hyperplasia in bleomycin-induced pulmonary fibrosis of rats. Am. Rev. Respir. Dis. 130, 797-802
13. Artuc, M., Hermes, B., Steckelings, U. M., Grützkau, A., and Henz, B. M. (1999) Mast cells and their mediators in cutaneous wound healing. Active participants or innocent bystanders? Exp. Dermatol. 8, 1-16
14. Braga, T., Grujic, M., Lukinius, A., Hellman, L., Abrink, M., and Pejler, G. (2007) Serglycin proteoglycan is required for secretory granule integrity in mucosal mast cells. Biochem. J. 403, 49-57
15. Ng, M. F. (2010) The Role of Mast Cells in Wound Healing. Int Wound J. 7, 55-61
16. Thompson, H. L., Burbelo, P. D., Gabriel, G., Yamada, Y., and Metcalfe, D. D. (1991) Murine mast cells synthesize basement membrane components. A potential role in early fibrosis. J. Clin. Invest. 87, 619-623
17. Passante, E., Ehrhardt, C, Sheridan, H., and Frankish, N. (2009) RBL-2H3 cells are an imprecise model for mast cell mediator release. Inflamm. Res. 58, 611-618
18. Alkhouri, H, Hollins, F., Moir, L. M., Brightling, C. E., Armour, C. L., and Hughes, J. M. (2011) Human lung mast cells modulate the functions of airway smooth muscle cells in asthma. Allergy 66, 1231-1241
19. Nilsson, G., Blom, T., Kusche-Gullberg, M., Kjellen, L., Butterfield, J. H, Sundstrom, C, Nilsson, K., and Hellman, L. (1994) Phenotypic characterization of the human mast-cell line HMC-1. Scand. J. Immunol. 39, 489-498
20. Caterson, B., Christner, J. E., and Baker, J. R. (1983) Identification of a monoclonal antibody that specifically recognized corneal and skeletal keratan sulfate. Monoclonal antibodies to cartilage proteoglycan. J. Biol. Chem. 258, 8848-8854
21. Theocharis, A. D., Seidel, C, Borset, M., Dobra, K., Baykov, V., Labropoulou, V., Kanakis, I., Dalas, E., Karamanos, N. K., Sundan, A., and Hjerpe, A. (2006) Serglycin constitutively secreted by myeloma plasma cells is a potent inhibitor of bone mineralisation in vitro. J. Biol. Chem. 281, 35116-35128
22. Whitelock, J. M., Graham, L. D., Melrose, J., Murdoch, A. D., Iozzo, R. V., and Underwood, P. A. (1999) Human perlecan immuno-purified from different endothelial cell sources has different adhesive properties for vascular cells. Matrix Biol. 18, 163-178
23. Knox, S., Merry, C., Stringer, S., Melrose, J., and Whitelock, J. (2002) Not all perlecans are created equal. Interactions with fibroblast growth factor (FGF) 2 and FGF receptors. J. Biol. Chem. 277, 14657-14665
24. Matsumoto, R., Sali, A., Ghildyal, N., Karplus, M., and Stevens, R. L. (1995) Packaging of proteases and proteoglycans in the granules of mast cells and other hematopoietic cells. A cluster of histidines on mouse mast cell protease 7 regulates its binding to heparin serglycin proteoglycans. J. Biol. Chem. 270, 19524-19531
25. Henningsson, F., Hergeth, S., Cortelius, R., Abrink, M., and Pejler, G. (2006) A role for serglycin proteoglycan in granular retention and processing of mast cell secretory granule components. FEBS J. 273, 4901-4912
26. Duelli, A., Rönnberg, E., Waern, I., Ringvall, M., Kolset, S. O., and Pejler, G. (2009) Mast cell differentiation and activation is closely linked to expression of genes coding for the serglycin proteoglycan core protein and a distinct set of chondroitin sulfate and heparin sulfotransferases. J. Immunol. 183, 7073-7083
27. Stevens, R. L., Avraham, S., Gartner, M. C., Bruns, G. A., Austen, K. F., and Weis, J. H. (1988) Isolation and characterization of a cDNA that encodes the peptide core of the secretory granule proteoglycan of human promyelocytic leukemia HL-60 cells. J. Biol. Chem. 263, 7287-7291
28. Thompson, H. L., Schulman, E. S., and Metcalfe, D. D. (1988) Identification of chondroitin sulfate E in human lung mast cells. J. Immunol. 140, 2708-2713
29. Gilead, L., Livni, N., Eliakim, R., Ligumsky, M., Fich, A., Okon, E., Rachmilewitz, D., and Razin, E. (1987) Human gastric mucosal mast cells are chondroitin sulphate E-containing mast cells. Immunology 62, 23-28
30. Katz, H. R., Austen, K. F., Caterson, B., and Stevens, R. L. (1986) Secretory granules of heparin-containing rat serosal mast cells also possess highly sulfated chondroitin sulfate proteoglycans. J. Biol. Chem. 261, 13393-13396
31. Seldin, D. C., Austen, K. F., and Stevens, R. L. (1985) Purification and characterization of protease-resistant secretory granule proteoglycans containing chondroitin sulfate di-B and heparin-like glycosaminoglycans from rat basophilic leukemia cells. J. Biol. Chem. 260, 11131-11139
32. Levi-Schaffer, F., Austen, K. F., Gravallese, P. M., and Stevens, R. L. (1986) Coculture of interleukin 3-dependent mouse mast cells with fibroblasts results in a phenotypic change of the mast cells. Proc. Natl. Acad. Sci. U. S. A. 83, 6485-6488
33. Murdoch, A. D., Liu, B., Schwarting, R., Tuan, R. S., and Iozzo, R. V. (1994) Widespread expression ofperlecan proteoglycanin basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization. J. Histochem. Cytochem. 42, 239-249
34. Couchman, J. R., Ljubimov, A. V., Sthanam, M., Horchar, T., and Hassell, J. R. (1995) Antibody mapping and tissue localization of globular and cysteine-rich regions of perlecan domain III. J. Histochem. Cytochem. 43, 955-963
35. Melrose, J., Roughley, P., Knox, S., Smith, S., Lord, M., and Whitelock, J. (2006) The structure, location, and function of perlecan, a prominent pericellular proteoglycan of fetal, postnatal, and mature hyaline cartilages. J. Biol. Chem. 281, 36905-36914
36. West, L., Govindraj, P., Koob, T. J., and Hassell, J. R. (2006) Changes in perlecan during chondrocyte differentiation in the fetal bovine rib growth plate. J. Orthop. Res. 24, 1317-1326
37. Whitelock, J. M., Murdoch, A. D., Iozzo, R. V., and Underwood, P. A. (1996) The degradation of human endothelial cell-derived perlecan, and release of bound bFGF, by stromelysin, plasmin and heparanases. J. Biol. Chem. 271, 10079-10086
38. Gonzalez, E. M., Reed, C. C., Bix, G., Fu, J., Zhang, Y., Gopalakrishnan, B., Greenspan, D. S., and Iozzo, R. V. (2005) BMP-1/Tolloid-like metalloproteases process endorepellin, the angiostatic C-terminal fragment of perlecan. J. Biol. Chem. 280, 7080-7087
39. Cailhier, J. F., Sirois, I., Laplante, P., Lepage, S., Raymond, M. A., Brassard, N., Prat, A., Iozzo, R. V., Pshezhetsky, A. V., and Hébert, M. J. (2008) Caspase-3 activation triggers extracellular cathepsin L release and endorepellin proteolysis. J. Biol. Chem. 283, 27220-27229
40. Oda, O., Shinzato, T., Ohbayashi, K., Takai, I., Kunimatsu, M., Maeda, K., and Yamanaka, N. (1996) Purification and characterization of perlecan fragment in urine of end-stage renal failure patients. Clin. Chim. Acta 255, 119-132
41. Parker, T. J., Sampson, D. L., Broszczak, D., Chng, Y. L., Carter, S. L., Leavesley, D. I., Parker, A. W., and Upton, Z. (2012) A fragment of the LG3 peptide of endorepellin is present in the urine of physically active mining workers. A potential marker of physical activity. PLoS One 7, e33714
42. Chang, J. W., Kang, U. B., Kim, D. H., Yi, J. K., Lee, J. W., Noh, D. Y., Lee, C., and Yu, M. H. (2008) Identification of circulating endorepellin LG3 fragment. Potential use as a serological biomarker for breast cancer proteomics. Clin. Appl. 2, 23-32
43. Bix, G., Fu, J., Gonzalez, E. M., Macro, L., Barker, A., Campbell, S., Zutter, M. M., Santoro, S. A., Kim, J. K., Hoök, M., Reed, C. C, and Iozzo, R. V. (2004) Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through α2β1 integrin. J. Cell. Biol. 166, 97-109
44. Bix, G., Iozzo, R. A., Woodall, B., Burrows, M., McQuillan, A., Campbell, S., Fields, G. B., and Iozzo, R. V. (2007) Endorepellin, the C-terminal angiostatic module of perlecan, enhances collagen-platelet responses via the alpha2beta1-integrin receptor. Blood 109, 3745-3748
45. Lee, B., Clarke, D., Al Ahmad, A., Kahle, M., Parham, C, Auckland, L., Shaw, C, Fidanboylu, M., Orr, A. W., Ogunshola, O., Fertala, A., Thomas, S. A., and Bix, G. J. (2011) Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodents. J. Clin. Invest. 121, 3005-3023
46. Laplante, P., Raymond, M. A., Labelle, A., Abe, J., Iozzo, R. V., and Hebert, M. J. (2006) Perlecan proteolysis induces an α2β1 integrin-and Src family kinase-dependent anti-apoptotic pathway in fibroblasts in the absence of focal adhesion kinase activation. J. Biol. Chem. 281, 30383-30392
47. Soulez, M., Sirois, I., Brassard, N., Raymond, M. A., Nicodeme, F., Noiseux, N., Durocher, Y., Pshezhetsky, A. V., and Hebert, M. J. (2010) Epidermal growth factor and perlecan fragments produced by apoptotic endothelial cells co-ordinately activate ERK1/2-dependent antiapoptotic pathways in mesenchymal stem cells. Stem Cells 28, 810-820
48. Soulez, M., Pilon, E. A., Dieude, M., Cardinal, H., Brassard, N., Qi, S., Wu, S. J., Durocher, Y., Madore, F., Perreault, C, and Hebert, M. J. (2012) The perlecan fragment LG3 is a novel regulator of obliterative remodeling associated with allograft vascular rejection. Circ. Res. 110, 94-104
49. Cohen, I. R., Grassel, S., Murdoch, A. D., and Iozzo, R. V. (1993) Structural characterization of the complete human perlecan gene and its promoter. Proc. Natl. Acad. Sci. U. S. A. 90, 10404-10408
50. Murdoch, A. D., Dodge, G. R., Cohen, I., Tuan, R. S., and Iozzo, R. V. (1992) Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan). A chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. J. Biol. Chem. 267, 8544-8557
51. Iozzo, R. V., Pillarisetti, J., Sharma, B., Murdoch, A. D., Danielson, K. G., Uitto, J., and Mauviel, A. (1997) Structural and functional characterization of the human perlecan gene promoter. Transcriptional activation by transforming growth factor-β via a nuclear factor 1-binding element. J. Biol. Chem. 272, 5219-5228
52. Joseph, S. J., Ford, M. D., Barth, C, Portbury, S., Bartlett, P. F., Nurcombe, V., and Greferath, U. (1996) A proteoglycan that activates fibroblast growth factors during early neuronal development is a perlecan variant. Development 122, 3443-3452
53. Mullen, G. P., Rogalski, T. M., Bush, J. A., Gorji, P. R., and Moerman, D. G. (1999) Complex patterns of alternative splicing mediate the spatial and temporal distribution of perlecan/UNC-52 in Caenorhabditis elegans. Mol. Biol. Cell. 10, 3205-3221
54. Lundquist, E. A., Herman, R. K., Rogalski, T. M., Mullen, G. P., Moerman, D. G., and Shaw, J. E. (1996) The mec-8 gene of C. elegans encodes a protein with two RNA recognition motifs and regulates alternative splicing of unc-52 transcripts. Development 122, 1601-1610
55. Spike, C. A., Shaw, J. E., and Herman, R. K. (2001) Analysis of smu-1, a gene that regulates the alternative splicing of unc-52 pre-mRNA in Caenorhabditis elegans. Mol. Cell. Biol. 21, 4985-4995
56. Spartz, A. K., Herman, R. K., and Shaw, J. E. (2004) SMU-2 and SMU-1, Caenorhabditis elegans homologs of mammalian spliceosome-associated proteins RED and fSAP57, work together to affect splice site choice. Mol. Cell. Biol. 24, 6811-6823
57. Sköld, C. M., Ohkuni, Y., Liu, X. D., Numerof, R., and Rennard, S. I. (2001) Co-cultured human mast cells stimulate fibroblast-mediated contraction of collagen gels. Inflammation 25, 47-51
58. Tapanadechopone, P., Hassell, J. R., Rigatti, B., and Couchman, J. R. (1999) Localization of glycosaminoglycan substitution sites on domain V of mouse perlecan. Biochem. Biophys. Res. Commun. 265, 680-690
59. Mongiat, M., Sweeney, S. M., San Antonio, J. D., Fu, J., and Iozzo, R. V. (2003) Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan. J. Biol. Chem. 278, 4238-4249